Here's Why Billionaires Stanley Druckenmiller and Ken Griffin Are Loading Up on Eli Lilly Stock
Is this big pharma stock still a buy for investors who aren't billionaires?
Overview
The adage that "birds of a feather flock together" doesn't always apply to billionaire investors. Most of these super-successful individuals have their own unique strategies that are highly differentiated from other approaches.
However, that doesn't mean high-profile investors don't sometimes see eye-to-eye on a given stock. For example, Stanley Druckenmiller and Ken Griffin both loaded up on Eli Lilly (NYSE: LLY) stock in the second quarter of 2026. Here's why these billionaires are on the same wavelength when it comes to this big pharma stock.
Ken Griffin. Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.